[1] |
Cadavid Restrepo AM, Yang YR, McManus DP, et al. The landscape epidemiology of echinococcoses[J]. Infect Dis Poverty, 2016, 5: 13.
|
[2] |
马玉安, 尚文杰. 甘南藏族自治州棘球蚴病流行情况分析[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(5): 352-356.
|
[3] |
王东, 冯宇, 李凡, 等. 甘肃省藏区人群棘球蚴病流行现状调查及分析[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(2): 140-144.
|
[4] |
买买提江·吾买尔, 阿迪力·司马义, 伊斯拉音·乌斯曼. 2012年新疆维吾尔自治区人群棘球蚴病流行病学调查[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(3): 249-254.
|
[5] |
齐颜凤, 伍卫平. 棘球蚴病流行病学研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2013, 31(2): 143-148.
|
[6] |
全国人体重要寄生虫病现状调查办公室. 全国人体重要寄生虫病现状调查报告[J]. 中国寄生虫学与寄生虫病杂志, 2005, 23(增刊): 332-340.
|
[7] |
严俊, 胡桃, 雷正龙. 全国重点寄生虫病的防控形势与挑战[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6): 412-417.
|
[8] |
Hemphill A, Walker M.Drugs against echinococcosis[J]. Drug Design Rev, 2004, 1(4): 325-332.
|
[9] |
Reuter S, Buck A, Manfras B, et al. Structured treatment interruption in patients with alveolar echinococcosis[J]. Hepatology, 2004, 39(2): 509-517.
|
[10] |
张亚明, 张元明. 阿苯达唑致小儿38例不良反应文献分析[J]. 中国医院药学杂志, 2007, 27(11): 1633-1634.
|
[11] |
郑荣远, 朱振国, 杨学志, 等. 阿苯达唑上市后安全性再评价报告[J]. 药物流行病学杂志, 2008, 17(1): 13-16.
|
[12] |
Horton RJ.Chemotherapy of Echinococcus infection in man with albendazole[J]. Trans R Soc Trop Med Hyg, 1989, 83(1): 97-102.
|
[13] |
McManus DP, Smyth JD. Intermediary carbohydrate metabolism in protoscoleces of Echinococcus granulosus (horse and sheep strains) and E. multilocularis[J]. Parasitology, 1982, 84(Pt 2): 351-366.
|
[14] |
王镜岩, 朱圣庚, 徐长法. 生物化学(下册)[M]. 北京: 高等教育出版社, 2002: 76.
|
[15] |
Elitok B, Elitok OM, Kabu M.Field trial on comparative efficacy of four fasciolicides against natural liver fluke infection in cattle[J]. Vet Parasitol, 2006, 135(3/4): 279-285.
|
[16] |
Coles GC, Stafford KA.Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica[J]. Vet Rec, 2001, 148(23): 723-724.
|
[17] |
Hutchinson GW, Dawson K, Fitzgibbon CC, et al. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle[J]. Vet Parasitol, 2009, 162(3/4): 278-284.
|
[18] |
Lamp KC, Freeman CD, Klutman NE, et al. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials[J]. Clin Pharmacokinet, 1999, 36(5): 353-373.
|
[19] |
Löfmark S, Edlund C, Nord CE.Metronidazole is still the drug of choice for treatment of anaerobic infections[J]. Clin Infect Dis, 2010, 50(Suppl 1): S16-S23.
|
[20] |
Schulman MD, Ostlind DA, Valentino D.Mechanism of action of MK-401 against Fasciola hepatica: inhibition of phosphoglycerate kinase[J]. Mol Biochem Parasitol, 1982, 5(3): 133-145.
|
[21] |
Jones AR, Cooper TG.Metabolism of 36Cl-ornidazole after oral application to the male rat in relation to its antifertility activity[J]. Xenobiotica, 1997, 27(7): 711-721.
|
[22] |
Stettler M, Siles-Lucas M, Sarciron E, et al. Echinococcus multilocularis alkaline phosphatase as a marker for metacestode damage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone[J]. Antimicrob Agents Chemother, 2001, 45(8): 2256-2262.
|